Working… Menu

Cerebrotendinous Xanthomatosis (CTX) Prevalence Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02638220
Recruitment Status : Unknown
Verified November 2018 by Travere Therapeutics, Inc..
Recruitment status was:  Recruiting
First Posted : December 23, 2015
Last Update Posted : November 9, 2018
Information provided by (Responsible Party):
Travere Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2018